Stockreport

New data show earlier start of treatment with Spinraza may improve motor function in SMA patients; Biogen up 2% premarket [Seeking Alpha]

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF New data show earlier start of treatment with Spinraza may improve motor function in SMA patients; Biogen up 2% premarketBiogen (NASDAQ:BIIB) is up2% premarket on light [Read more]